Sign In
Buy ABBV
$227.23
+2.30 (+1.02%)
At Close: Jun 05, 2026
2 "Safe" Stocks That Are Anything But
11:15am, Friday, 30'th Dec 2022 The Motley Fool
Sometimes, business models that sound safe still fail to deliver for shareholders.
AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It
10:32am, Friday, 30'th Dec 2022
Zacks.com users have recently been watching AbbVie (ABBV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Pfizer (PFE) Pentavalent Meningitis Jab BLA Gets FDA Acceptance
01:53pm, Thursday, 29'th Dec 2022 Zacks Investment Research
The FDA assigns a standard review to Pfizer's (PFE) BLA for pentavalent meningococcal vaccine candidate (MenABCWY), with a decision expected in October 2023.
Selecting Dividend Aristocrats Using SCHD's Methodology - Initial Results
10:15am, Thursday, 29'th Dec 2022
I propose leveraging the stock selection criteria from the underlying index of SCHD to build a portfolio with a subset of Dividend Aristocrats. I am tracking two portfolios built using this process an
3 High-Yield Dividend Stocks to Supercharge Your Passive Income Portfolio
10:13am, Thursday, 29'th Dec 2022 The Motley Fool
Here are three dividend-paying stocks that could help fuel your retirement dreams.
FDA Approval, Top Funds Lift Drugmaker In Ailing Market
08:05am, Thursday, 29'th Dec 2022
Boosted by demand among the best mutual funds and an FDA approval, AbbVie shows strength in ailing market. The post FDA Approval, Top Funds Lift Drugmaker In Ailing Market appeared first on Investor's
3 High-Yield Dividend Stocks to Supercharge Your Passive Income Portfolio
05:13am, Thursday, 29'th Dec 2022
Here are three dividend-paying stocks that could help fuel your retirement dreams.
Our Predictions for the Top 7 Dividend Stocks for 2023
01:28pm, Wednesday, 28'th Dec 2022
In this article, I'll give you my dividend stock predictions for 2023. Because let's be honest, most investors can't say goodbye to 2022 fast enough.
The Zacks Analyst Blog Highlights AbbVie, PepsiCo, Oracle, HSBC Holdings and The Progressive
12:53pm, Wednesday, 28'th Dec 2022 Zacks Investment Research
AbbVie, PepsiCo, Oracle, HSBC Holdings and The Progressive are part of the Zacks top Analyst Blog.
AbbVie (ABBV) Stock Moves -0.07%: What You Should Know
10:45pm, Tuesday, 27'th Dec 2022 Zacks Investment Research
AbbVie (ABBV) closed the most recent trading day at $162.99, moving -0.07% from the previous trading session.
3 Dividend Kings Nicely Suited for Income Investors
08:09pm, Tuesday, 27'th Dec 2022 Zacks Investment Research
Dividend Aristocrats, companies that have increased their dividend payouts for at least 25 consecutive years, are popular targets among income investors. However, a step above is the elite Dividend Ki
Top Analyst Reports for AbbVie, PepsiCo & Oracle
08:04pm, Tuesday, 27'th Dec 2022 Zacks Investment Research
Today's Research Daily features new research reports on 16 major stocks, including AbbVie Inc. (ABBV), PepsiCo, Inc. (PEP) and Oracle Corporation (ORCL).
3 Dividend Kings Nicely Suited for Income Investors
04:32pm, Tuesday, 27'th Dec 2022
Dividend Aristocrats, companies that have increased their dividend payouts for at least 25 consecutive years, are popular targets among income investors. However, a step above is the elite Dividend Ki
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
02:20pm, Saturday, 24'th Dec 2022 The Motley Fool
These companies are safe havens during tough times, with above-average dividends.
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
09:20am, Saturday, 24'th Dec 2022
These companies are safe havens during tough times, with above-average dividends.
